Type
. Letter: Sulphone resistance in leprosy. Lancet (London, England). 1975;2(7928):280.
Type
. Letter: Sulphone resistance in leprosy. Lancet (London, England). 1975;2(7926):177.
Type
. Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Lancet (London, England). 1975;2(7924):69-72.
Type
. Achievements in tropical medicine during the past twenty-five years. The British journal of clinical practice. 1971;25(12):529-35.
Type
. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Clinical and experimental immunology. 1971;9(6):821-31.
Type
. Fate of Mycobacterium leprae in macrophages. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1971;39(4):896.
Type
. Margaret FitzHerbert 1906-1971. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1971;39(4):894-5.
Type
. WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bulletin of the World Health Organization [Internet]. 1971;45(6):719-32. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427977/pdf/bullwho00199-0029.pdf
Type
. Statistical calculations of the confidence interval and significant difference ranges of the morphologic index. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1971;39(4):852-62.
Type
. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1971;39(4):829-37.